{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:48:07Z","timestamp":1782128887276,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24K10385"],"award-info":[{"award-number":["24K10385"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["25K19910"],"award-info":[{"award-number":["25K19910"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Pancreas Research Foundation of Japan"},{"name":"Basis for Supporting Innovative Drug Discovery and Life Science Research","award":["JP24ama121054"],"award-info":[{"award-number":["JP24ama121054"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49380-8","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:01:04Z","timestamp":1777122064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methylation heterogeneity of the AQP1 promoter as a candidate prognostic biomarker in cholangiocarcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Seiya","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Akahane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikumi","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiyo","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiko","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"7","key":"49380_CR1","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i7.107995","volume":"17","author":"MM Hussain","year":"2025","unstructured":"Hussain, M. M., Wang, J. M., Zhai, A. Q., Li, F. Y. & Hu, H. J. Comparison of prognostic factors and their differences in intrahepatic, hilar, and distal cholangiocarcinoma: A systematic review and meta-analysis. World J. Gastrointest. Oncol. 17(7), 107995 (2025).","journal-title":"World J. Gastrointest. Oncol."},{"issue":"1","key":"49380_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100378","volume":"7","author":"A Lamarca","year":"2022","unstructured":"Lamarca, A., Edeline, J. & Goyal, L. How I treat biliary tract cancer. ESMO Open 7(1), 100378 (2022).","journal-title":"ESMO Open"},{"issue":"Suppl 1","key":"49380_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/liv.14089","volume":"39","author":"U Cillo","year":"2019","unstructured":"Cillo, U. et al. Surgery for cholangiocarcinoma. Liver Int. 39(Suppl 1), 143\u2013155 (2019).","journal-title":"Liver Int."},{"key":"49380_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4137\/CMO.S32821","volume":"10","author":"EU Cidon","year":"2016","unstructured":"Cidon, E. U. Resectable cholangiocarcinoma: Reviewing the role of adjuvant strategies. Clin. Med. Insights Oncol. 10, 43\u201348 (2016).","journal-title":"Clin. Med. Insights Oncol."},{"issue":"9","key":"49380_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales, J. M. et al. Cholangiocarcinoma 2020: The next horizon in mechanisms and management. Nat. Rev. Gastroenterol. Hepatol. 17(9), 557\u2013588 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"49380_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.hpb.2017.08.025","volume":"20","author":"JLA van Vugt","year":"2018","unstructured":"van Vugt, J. L. A. et al. The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma. HPB (Oxford) 20(1), 83\u201392 (2018).","journal-title":"HPB (Oxford)"},{"issue":"2","key":"49380_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/bjs.8950","volume":"100","author":"O Farges","year":"2013","unstructured":"Farges, O. et al. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br. J. Surg. 100(2), 274\u2013283 (2013).","journal-title":"Br. J. Surg."},{"issue":"4","key":"49380_CR8","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2021.2234","volume":"14","author":"Y Sota","year":"2021","unstructured":"Sota, Y. et al. Recurrent cholangiocarcinoma with long-term survival by multimodal treatment: A case report. Mol. Clin. Oncol. 14(4), 72 (2021).","journal-title":"Mol. Clin. Oncol."},{"key":"49380_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132959","author":"J Bednarsch","year":"2021","unstructured":"Bednarsch, J. et al. Compelling long-term results for liver resection in early cholangiocarcinoma. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm10132959 (2021).","journal-title":"J. Clin. Med."},{"issue":"7","key":"49380_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304838","volume":"19","author":"A Mantas","year":"2024","unstructured":"Mantas, A. et al. Clinical features and prediction of long-term survival after surgery for perihilar cholangiocarcinoma. PLoS ONE 19(7), e0304838 (2024).","journal-title":"PLoS ONE"},{"issue":"1","key":"49380_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tips.2021.10.009","volume":"43","author":"MM Salman","year":"2022","unstructured":"Salman, M. M., Kitchen, P., Yool, A. J. & Bill, R. M. Recent breakthroughs and future directions in drugging aquaporins. Trends Pharmacol. Sci. 43(1), 30\u201342 (2022).","journal-title":"Trends Pharmacol. Sci."},{"issue":"Pt 15","key":"49380_CR12","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1242\/jcs.02519","volume":"118","author":"AS Verkman","year":"2005","unstructured":"Verkman, A. S. More than just water channels: Unexpected cellular roles of aquaporins. J. Cell Sci. 118(Pt 15), 3225\u20133232 (2005).","journal-title":"J. Cell Sci."},{"issue":"10 Pt B","key":"49380_CR13","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1016\/j.bbamem.2014.09.001","volume":"1848","author":"MC Papadopoulos","year":"2015","unstructured":"Papadopoulos, M. C. & Saadoun, S. Key roles of aquaporins in tumor biology. Biochim. Biophys. Acta 1848(10 Pt B), 2576\u20132583 (2015).","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"49380_CR14","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.bbagen.2013.09.025","volume":"1840","author":"D Ribatti","year":"2014","unstructured":"Ribatti, D., Ranieri, G., Annese, T. & Nico, B. Aquaporins in cancer. Biochim. Biophys. Acta 1840(5), 1550\u20131553 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"49380_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ajpath.2025.10.007","volume":"196","author":"C Gaspari","year":"2025","unstructured":"Gaspari, C. et al. Loss of aquaporin-1 in tumor cells fosters intrahepatic cholangiocarcinoma progression. Am. J. Pathol. 196, 428\u2013444 (2025).","journal-title":"Am. J. Pathol."},{"issue":"2","key":"49380_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.amjms.2021.11.004","volume":"364","author":"S Xu","year":"2022","unstructured":"Xu, S. et al. The expression of Aquaporin-1 and Aquaporin-3 in extrahepatic cholangiocarcinoma and their clinicopathological significance. Am. J. Med. Sci. 364(2), 181\u2013191 (2022).","journal-title":"Am. J. Med. Sci."},{"issue":"4","key":"49380_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/1533034616646288","volume":"16","author":"C Li","year":"2017","unstructured":"Li, C., Li, X., Wu, L. & Jiang, Z. Elevated AQP1 expression is associated with unfavorable oncologic outcome in patients with hilar cholangiocarcinoma. Technol. Cancer Res. Treat. 16(4), 421\u2013427 (2017).","journal-title":"Technol. Cancer Res. Treat."},{"issue":"1","key":"49380_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01003-7","volume":"9","author":"HE Marei","year":"2025","unstructured":"Marei, H. E. Epigenetic regulators in cancer therapy and progression. npj Precis. Oncol. 9(1), 206 (2025).","journal-title":"npj Precis. Oncol."},{"issue":"1","key":"49380_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13148-025-01884-2","volume":"17","author":"A Lavoro","year":"2025","unstructured":"Lavoro, A. et al. Recent advances on gene-related DNA methylation in cancer diagnosis, prognosis, and treatment: A clinical perspective. Clin. Epigenet. 17(1), 76 (2025).","journal-title":"Clin. Epigenet."},{"issue":"11","key":"49380_CR20","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama, A. & Nakanishi, M. Navigating the DNA methylation landscape of cancer. Trends Genet. 37(11), 1012\u20131027 (2021).","journal-title":"Trends Genet."},{"issue":"1","key":"49380_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02266-z","volume":"10","author":"J Song","year":"2025","unstructured":"Song, J. et al. Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance. Signal Transduct. Target Ther. 10(1), 219 (2025).","journal-title":"Signal Transduct. Target Ther."},{"issue":"6","key":"49380_CR22","doi-asserted-by":"publisher","first-page":"873","DOI":"10.4161\/epi.28571","volume":"9","author":"AA Smith","year":"2014","unstructured":"Smith, A. A. et al. A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression. Epigenetics 9(6), 873\u2013883 (2014).","journal-title":"Epigenetics"},{"issue":"2","key":"49380_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/15592294.2019.1580112","volume":"14","author":"E Smith","year":"2019","unstructured":"Smith, E. et al. Reduced Aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylation. Epigenetics 14(2), 158\u2013170 (2019).","journal-title":"Epigenetics"},{"issue":"5","key":"49380_CR24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/0194599814521569","volume":"150","author":"M Tan","year":"2014","unstructured":"Tan, M. et al. Aquaporin-1 promoter hypermethylation is associated with improved prognosis in salivary gland adenoid cystic carcinoma. Otolaryngol. Head Neck Surg. 150(5), 801\u2013807 (2014).","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"10","key":"49380_CR25","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1158\/1078-0432.CCR-19-1247","volume":"26","author":"S Yokoyama","year":"2020","unstructured":"Yokoyama, S. et al. Predicted prognosis of patients with pancreatic cancer by machine learning. Clin. Cancer Res. 26(10), 2411\u20132421 (2020).","journal-title":"Clin. Cancer Res."},{"issue":"27","key":"49380_CR26","doi-asserted-by":"publisher","first-page":"42553","DOI":"10.18632\/oncotarget.9924","volume":"7","author":"S Yokoyama","year":"2016","unstructured":"Yokoyama, S. et al. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas. Oncotarget 7(27), 42553\u201342565 (2016).","journal-title":"Oncotarget"},{"issue":"4","key":"49380_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093760","volume":"9","author":"S Yokoyama","year":"2014","unstructured":"Yokoyama, S. et al. Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice. PLoS ONE 9(4), e93760 (2014).","journal-title":"PLoS ONE"},{"key":"49380_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-67","volume":"12","author":"S Yokoyama","year":"2012","unstructured":"Yokoyama, S. et al. The application of methylation specific electrophoresis (MSE) to DNA methylation analysis of the 5\u2019 CpG island of mucin in cancer cells. BMC Cancer 12, 67 (2012).","journal-title":"BMC Cancer"},{"key":"49380_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/978-1-0716-3670-1_22","volume":"2763","author":"S Yokoyama","year":"2024","unstructured":"Yokoyama, S., Matsuo, K. & Tanimoto, A. Methylation-specific electrophoresis. Methods. Mol. Biol. 2763, 259\u2013268 (2024).","journal-title":"Methods. Mol. Biol."},{"issue":"1","key":"49380_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-21715-x","volume":"15","author":"S Yokoyama","year":"2025","unstructured":"Yokoyama, S. et al. MUC1 promoter methylation pattern diversity and its association with TET3 expression and prognosis in cholangiocarcinoma. Sci. Rep. 15(1), 37894 (2025).","journal-title":"Sci. Rep."},{"issue":"11","key":"49380_CR31","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/dc.25022","volume":"50","author":"S Yokoyama","year":"2022","unstructured":"Yokoyama, S. et al. Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-based cytology specimens of pancreatic cancer. Diagn. Cytopathol. 50(11), 499\u2013507 (2022).","journal-title":"Diagn. Cytopathol."},{"issue":"11","key":"49380_CR32","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.humpath.2005.09.002","volume":"36","author":"PR Mazal","year":"2005","unstructured":"Mazal, P. R., Susani, M., Wrba, F. & Haitel, A. Diagnostic significance of aquaporin-1 in liver tumors. Hum. Pathol. 36(11), 1226\u20131231 (2005).","journal-title":"Hum. Pathol."},{"issue":"4","key":"49380_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S1665-2681(19)32090-3","volume":"3","author":"RA Marinelli","year":"2004","unstructured":"Marinelli, R. A., Gradilone, S. A., Carreras, F. I., Calamita, G. & Lehmann, G. L. Liver aquaporins: Significance in canalicular and ductal bile formation. Ann. Hepatol. 3(4), 130\u2013136 (2004).","journal-title":"Ann. Hepatol."},{"issue":"4","key":"49380_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4132\/jptm.2016.03.30","volume":"50","author":"S Yun","year":"2016","unstructured":"Yun, S. et al. Aquaporin 1 is an independent marker of poor prognosis in lung adenocarcinoma. J. Pathol. Transl. Med. 50(4), 251\u2013257 (2016).","journal-title":"J. Pathol. Transl. Med."},{"key":"49380_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","volume":"31","author":"J Pastorek","year":"2015","unstructured":"Pastorek, J. & Pastorekova, S. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use. Semin. Cancer Biol. 31, 52\u201364 (2015).","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"49380_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101053","volume":"9","author":"F Visioli","year":"2014","unstructured":"Visioli, F. et al. Glucose-regulated protein 78 (Grp78) confers chemoresistance to tumor endothelial cells under acidic stress. PLoS ONE 9(6), e101053 (2014).","journal-title":"PLoS ONE"},{"issue":"7494","key":"49380_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature13119","volume":"508","author":"X Chen","year":"2014","unstructured":"Chen, X. et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway. Nature 508(7494), 103\u2013107 (2014).","journal-title":"Nature"},{"issue":"1","key":"49380_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2014.12.002","volume":"27","author":"ZT Schug","year":"2015","unstructured":"Schug, Z. T. et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 27(1), 57\u201371 (2015).","journal-title":"Cancer Cell"},{"issue":"9","key":"49380_CR39","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.celrep.2017.02.006","volume":"18","author":"A Kondo","year":"2017","unstructured":"Kondo, A. et al. Extracellular acidic pH activates the sterol regulatory element-binding protein 2 to promote tumor progression. Cell Rep. 18(9), 2228\u20132242 (2017).","journal-title":"Cell Rep."},{"issue":"1","key":"49380_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12867-018-0104-9","volume":"19","author":"Y Zhai","year":"2018","unstructured":"Zhai, Y. et al. pH-mediated upregulation of AQP1 gene expression through the Spi-B transcription factor. BMC Mol. Biol. 19(1), 4 (2018).","journal-title":"BMC Mol. Biol."},{"issue":"12","key":"49380_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028385","volume":"6","author":"I Abreu-Rodriguez","year":"2011","unstructured":"Abreu-Rodriguez, I. et al. Functional and transcriptional induction of aquaporin-1 gene by hypoxia; analysis of promoter and role of Hif-1alpha. PLoS ONE 6(12), e28385 (2011).","journal-title":"PLoS ONE"},{"issue":"3","key":"49380_CR42","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jmoldx.2012.01.014","volume":"14","author":"SH Shin","year":"2012","unstructured":"Shin, S. H. et al. Bile-based detection of extrahepatic cholangiocarcinoma with quantitative DNA methylation markers and its high sensitivity. J. Mol. Diagn. 14(3), 256\u2013263 (2012).","journal-title":"J. Mol. Diagn."},{"issue":"2","key":"49380_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.01429-21","volume":"9","author":"M Jensen","year":"2021","unstructured":"Jensen, M., Wippler, J. & Kleiner, M. Evaluation of RNAlater as a field-compatible preservation method for metaproteomic analyses of bacterium-animal symbioses. Microbiol. Spectr. 9(2), e0142921 (2021).","journal-title":"Microbiol. Spectr."},{"issue":"11","key":"49380_CR44","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","volume":"27","author":"F Krueger","year":"2011","unstructured":"Krueger, F. & Andrews, S. R. Bismark: A flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics 27(11), 1571\u20131572 (2011).","journal-title":"Bioinformatics"},{"key":"49380_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-0950-8","volume":"17","author":"NC Wong","year":"2016","unstructured":"Wong, N. C. et al. MethPat: A tool for the analysis and visualisation of complex methylation patterns obtained by massively parallel sequencing. BMC Bioinform. 17, 98 (2016).","journal-title":"BMC Bioinform."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49380-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49380-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49380-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:04:38Z","timestamp":1782126278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49380-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49380"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49380-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The ethics committee of Kagoshima University Hospital (revised 26\u2013145) approved the IRB application titled \u201cEstablishment of a System for the Early Diagnosis and Staging of Pancreatobiliary Cancers Using Pancreatic Juice, Bile, and Duodenal Juice,\u201d which covers the collection, storage, and research use of the tissue samples. Written informed consent was obtained from each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"19208"}}